Literature DB >> 9921765

Proximal phalanx osteotomy for the surgical treatment of hallux rigidus.

P J Thomas1, R W Smith.   

Abstract

This study reviewed 17 patients (24 great toes) treated by a single surgeon for hallux rigidus with a dorsal-closing wedge osteotomy of the proximal phalanx in conjunction with a moderate cheilectomy. The average age of patients was 47 years (range, 20-69 years). The minimum follow-up was 1 year (range, 1-16 years; median follow-up, 30 months), and all but five patients were studied for 2 years or more. Ninety-six percent of patients affirmed their decision to have surgery if they had to make the choice again. Subjectively, all patients improved. Preoperatively, 67% of the cases had severe pain by American Orthopaedic Foot and Ankle Society criteria. Postoperatively, 58% had no pain and 42% had mild pain. There was 100% union rate of the osteotomy. Seven of 10 women and 1 of 7 men still had some restrictions on footwear options postoperatively. Recovery time from the patients' perspective was 2 to 12 months (average, 5.6 months). Based on the results of this study, the authors suggest that the addition of a dorsal-closing wedge osteotomy of the proximal phalanx increases patient satisfaction, compared with their review of patients treated by cheilectomy alone. The procedure provides good pain relief and has few complications.

Entities:  

Mesh:

Year:  1999        PMID: 9921765     DOI: 10.1177/107110079902000102

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  3 in total

Review 1.  [Surgical treatment of hallux rigidus].

Authors:  G Dereymaeker
Journal:  Orthopade       Date:  2005-08       Impact factor: 1.087

Review 2.  Hallux rigidus: Joint preserving alternatives to arthrodesis - a review of the literature.

Authors:  Hans Polzer; Sigmund Polzer; Mareen Brumann; Wolf Mutschler; Markus Regauer
Journal:  World J Orthop       Date:  2014-01-18

Review 3.  Hallux rigidus.

Authors:  Bryant Ho; Judith Baumhauer
Journal:  EFORT Open Rev       Date:  2017-03-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.